VKH
ATHE

Virtu KCG Holdings’s Alterity Therapeutics ATHE Stock Holding History

Virtu KCG Holdings’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,310
Closed -$38K – 3111
2016
Q4 		$38K Buy
2,310
+331
+17% +$8.85K ﹤0.01% 3145
2016
Q3 		$89K Buy
1,979
+853
+76% +$42.5K ﹤0.01% 2663
2016
Q2 		$53K Buy
+1,126
New +$43.3K ﹤0.01% 2668
2016
Q1 		– Sell
-1,802
Closed -$78K – 2776
2015
Q4 		$78K Buy
1,802
+1,289
+251% +$65.6K ﹤0.01% 3062
2015
Q3 		$28K Sell
513
-1,940
-79% -$123K ﹤0.01% 3103
2015
Q2 		$172K Buy
2,453
+2,166
+755% +$163K ﹤0.01% 2679
2015
Q1 		$19K Sell
287
-2,369
-89% -$189K ﹤0.01% 2965
2014
Q4 		$261K Buy
2,656
+2,386
+884% +$258K ﹤0.01% 2525
2014
Q3 		$34K Buy
270
+73
+37% +$9.77K ﹤0.01% 3412
2014
Q2 		$27K Sell
197
-498
-72% -$56.8K ﹤0.01% 3500
2014
Q1 		$116K Sell
695
-187
-21% -$103K ﹤0.01% 3167
2013
Q4 		$370K Buy
882
+687
+352% +$206K ﹤0.01% 2315
2013
Q3 		$48K Buy
+195
New +$44.8K ﹤0.01% 3518

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Virtu KCG Holdings's ATHE Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Alterity Therapeutics (ATHE) in Q1 2017, closing a stake of 2,310 shares — an estimated $38K sold.

Virtu KCG Holdings first reported a position in ATHE in Q3 2013 and held it in 13 quarters. The position peaked at $370K in Q4 2013. 11 funds tracked by Wall St. Rank hold ATHE as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Alterity Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 2,310 Alterity Therapeutics shares in Q1 2017, an estimated $38K.
  • Virtu KCG Holdings first reported a position in Alterity Therapeutics in Q3 2013 and held it in 13 quarters.
  • Virtu KCG Holdings's Alterity Therapeutics position peaked at $370K in Q4 2013.
  • 11 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.